Data from the Phase III FRONTIER3 trial found that 98% of caregivers prefer Mim8 for hemophilia A over other treatments.

The study revealed the risk of developing venous thromboembolisms from various types of synthetic hormones, providing ...

Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the ...

Rep. Chip Roy (R-TX) issued a diagnosis for America’s broken health care system, and the congressman says the problem isn’t ...

“If we want to control our budgets and health care spending ... The drugmaker behind weight loss drugs Wegovy, Saxenda, and Ozempic, Novo Nordisk, has spent $25.8 million over the past decade ...

Robert F. Kennedy Jr. faces high-stakes Senate hearings as he seeks confirmation for Health Secretary. This live blog is now ...

RFK Jr.'s bid for top health job faces Senate committee hurdle on Tuesday Novo Nordisk's blockbuster ... insurance access to over-the-counter birth control pills and other contraceptives at ...

A US federal judge has temporarily halted Donald Trump’s executive order to end citizenship at birth. Earlier this ... they exploded in popularity. Novo Nordisk, which makes Ozempic, became ...

Baseline characteristics of children with FED and their matched control subjects (n = 19,670 ... 81703237, 81930095, and 82073570), the Novo Nordisk Foundation (NNF18OC0052029), the Danish Council for ...

Infant mortality in the U.S. has increased by 7% since the 2022 Dobbs v. Jackson U.S. Supreme Court decision overturned the ...